Clinical Trial Update: JY016 Injection in Patients With Advanced Solid Tumors Expressing EGFR [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of JY016 for advanced solid tumors expressing EGFR, with the trial currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• JY016

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Solid Cancers | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING